[A pilot study of alternate combination chemotherapy with rhG-CSF for adult T-cell leukemia/lymphoma].
Kikuchi
H
H
2nd Dept. of Internal Medicine, Oita Medical University.
Ono
K
K
Ohtsuka
E
E
Nakayama
T
T
Hirota
K
K
Tezono
K
K
Ogata
M
M
Hori
T
T
Saburi
Y
Y
Nasu
M
M
D000328:Adult; D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D004334:Drug Administration Schedule; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000628:therapy*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D010865:Pilot Projects; D011994:Recombinant Proteins / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D004317:Doxorubicin; C027260:pirarubicin; D008727:Methotrexate